Featured In This Issue
- PCORnet® Network Resources Speed Results in Multisite Test 2 Treat Intervention Study
- PCORnet® Study Is First to Directly Compare Epilepsy Surgery with Anti-Seizure Medications for Patients with LGS
- Explore the PCORnet® Population with New Interactive Reports
Funding Opportunities: Read below for newly released PCORI® Funding Announcements in methods, engagement, and broad pragmatic studies, and share with your network of researchers.
Events: Join us in November for The Big Events Study: Examining the Short- and Long-Term Effects of Disasters on the Overdose Crisis.
Research Results: Follow PCORnetwork on LinkedIn for updates on new publications from more than 300 studies. Explore newly published results on heart failure, cognitive function, cardiovascular disease, and more and connect with peers engaged with the network.
A National Clinical Research Resource for Patient-Centered Comparative Clinical Effectiveness Research
Connect with us
Subscribe to receive the newsletter via email.
Complete the PCORnet® Front Door form to get in touch!
PCORnet® Network Resources Speed Results in Multisite Test 2 Treat Intervention Study
Managing low-density lipoprotein cholesterol (LDL-C) is a critical step in reducing the risk of future heart attacks and strokes, yet many patients leave the hospital without appropriate LDL-C testing or treatment. The PCORnet® Study Test 2 Treat aimed to identify practical strategies that could improve cholesterol management in real-world care settings. The study, which was funded by Amgen, evaluated two complementary approaches for patients hospitalized after a heart attack or stent placement to restore blood flow to the heart: a hospital-level intervention designed to improve LDL-C testing and treatment during hospitalization and a patient-level intervention designed to support cholesterol management after discharge. The study team leveraged patient and clinician partners and data resources available through PCORnet to design, implement, and provide a standardized foundation to evaluate the hospital-level intervention across five health systems.
Less than a year after the last participant enrolled, Co-Principal Investigator Nishant Shah, MD, at Duke University, shared the study results in a late-breaking presentation at the American Heart Association’s Scientific Sessions. The study demonstrated how partner insights, experienced site teams, and data resources available through PCORnet can support efficient, national-scale research to improve health outcomes.
PCORnet® Study Is First to Directly Compare Epilepsy Surgery with Additional Anti-Seizure Medications for Patients with LGS
A PCORnet® Study led by Sandi Lam, MD, MBA, at Lurie Children’s Hospital, is the first to directly compare epilepsy surgery with additional anti-seizure medications for patients with LGS. The study, Comparative Effectiveness of Epilepsy Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut syndrome (LGS), is leveraging partnerships with patients and caregivers and the national-scale data resources available through PCORnet to conduct rare disease research. Results of the study will help families and clinicians make better-informed decisions about the best treatment pathway for LGS.
Explore the PCORnet® Population with New Interactive Reports

New interactive PCORnet® Population Insights Reports give researchers a closer look at the demographic and clinical characteristics of patients who received healthcare services at sites participating in PCORnet®.
The reports use detailed visualizations and interactive tables to help researchers and clinicians explore the populations and data available through the PCORnet infrastructure. These insights can inform planning for observational research and pragmatic trials across a range of health conditions and healthcare settings.
The interactive tables reflect more than 50 million patients who had healthcare encounters at sites participating in PCORnet. The reports also describe the patient populations for the following health conditions:
- Cardiovascular Disease (14.5 million patients)
- Sensory Health Conditions (8.5 million patients)
- Cancer (4 million patients)
- Intellectual and Developmental Disabilities (3.8 million patients)
- Menopausal Conditions (2.7 million patients)
Users can filter results by cohort and explore characteristics such as demographics, geography, care setting, payer, co-occurring conditions, and treatments and services. Data tables can be downloaded from each report page for further analysis. Explore the reports to see how the PCORnet data resources may align with your research questions.
PCORI® Funding Opportunities Now Open

PCORI is now accepting Letter of Intent submissions for several PCORI Funding Announcements (PFAs). The Broad Pragmatic Studies (BPS) PFA will offer up to $12 million in direct costs through Category 3 to support PCORnet® Studies.
The Improving Methods for Conducting Patient-Centered Comparative Clinical Effectiveness Research (CER) PFA is also open. This PFA seeks to fund studies that address high-impact methodological gaps in patient-centered CER. LOI deadlines for all Cycle 1 2027 PFAs are due Jan. 6.
- Broad Pragmatic Studies
- Improving Methods for Conducting Patient-Centered Comparative Clinical Effectiveness Research
Additional PFAs with LOI due Jan. 6, 2027:
- Harnessing Digital Health Technologies to Support Patient-Centered Comparative Clinical Effectiveness Research
- Advancing the Science of Engagement in Research
- Phased Large Awards for Comparative Effectiveness Research(opens in new tab)
While PCORI funds many PCORnet® Studies, PCORI funding is not required to qualify as a PCORnet® Study or to leverage the PCORnet infrastructure for your research. Nearly 40% of PCORnet® Studies are funded by industry or large federal organizations such as the NIH.
Explore these learning opportunities to strengthen your research and gain insights from studies utilizing the PCORnet infrastructure.
Best Practices Sharing Session
Join us at the next session in the free monthly webinar series. Contact [email protected] for a calendar invite.
November 19 at 1 pm (ET)
Investigators from the PCORI-funded PCORnet® Study, Big Events, will share will present “The Big Events Study: Examining the short-and long-term effects of disasters on the overdose crisis.” In this session, presenters will use the study as a case example to discuss operational considerations including privacy-preserving patient linkage and tokenization, cross-site data quality review, and development of a reproducible opioid overdose outcome phenotype. Presenters will include:
- Ellicott Matthay, PhD, Epidemiologist and Assistant Professor, Department of Population Health, New York University Grossman School of Medicine
- Magdalena Cerdá, DrPH, Susan Dwight Bliss Professor of Chronic Disease Epidemiology, Yale School of Public Health
- Cameron McKay, PhD, Senior Data Analyst, New York University Langone Health
Recently published insights from study teams using the PCORnet infrastructure

Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial. American Heart Journal, January 2026; Goldenberg I, Zareba W, Ezekowitz JA, et al. (Funder: PCORI)
The THINK-TTP Study for Assessing Cognitive Function in Clinical Trials: A Qualitative Research Protocol. International Journal of Qualitative Methods, February 2026; Coles T, Mkumba L, Thompson D, et al. (Funder: National Institutes of Health/National Center for Advancing Translational Science)
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems. Circulation: Population Health and Outcomes, April 2026; Shah NP, Peterson ED, Shrader P, et al. (Funder: Amgen)
Adaption of DETECT for Use in Home-Based Primary Care: Clinician Perspectives. Journal of the American Geriatrics Society, May 2026; Lees Haggerty K, Campetti R, Ojelabi O, et al. (Funder: National Institutes of Health/National Institute on Aging)
Rational and design for test 2 treat: A randomized implementation trial to improve LDL-C management after hospitalization for ASCVD. American Journal of Preventative Cardiology, September 2026; Shah NP, Mulder H, Alhanti B, et al. (Funder: Amgen)
Injuries From Electric Bicycles and Scooters Managed in Pediatric Health Systems. JAMA, November 2026, Schroeder AR, Hall ES, Master S, et al. (Funder: PCORI)
Contact the PCORnet® Front Door

When you’re ready to learn how the PCORnet infrastructure can support your patient-centered health research, connect with the PCORnet® Front Door, your gateway to opportunities.
PCORnet® is on LinkedIn
Follow PCORnetwork on LinkedIn to join the conversation, stay connected, and get the latest updates on how the PCORnet infrastructure is improving the nation’s capacity to efficiently conduct patient-centered comparative clinical effectiveness research (CER) through research expertise, patient and community partner insights, and high-quality health data.
PCORnet® is intended to improve the nation’s capacity to efficiently conduct patient-centered health research, particularly comparative clinical effectiveness research (CER), by providing a large, highly representative network of health data, research expertise, and patient insights. PCORnet® has been developed with funding from the Patient-Centered Outcomes Research Institute (PCORI®).